WHO ICTRP trial
Immunity booster on respiratory tract infections
CTRI/2024/05/067252 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/05/067252 |
|---|---|
| Public title | Immunity booster on respiratory tract infections |
| Scientific title | An open label non comparative prospective clinical trial on the efficacy of BalRasayana syrup as an immunomodulator and its role in recurrent respiratory tract infections in children - IMB |
| Primary sponsor | GURUKRUPA AMRUTA AYURVEDA LLP |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: J209- Acute bronchitis, unspecified |
| Registration date | May 13, 2024 |
| Target size | 32 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: